Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Dow Inc
DOW
$22.4B
| $23.8M | 0.01% |
+462,108
| New | +$29.6M |
|
1602
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
| $23.8M | 0.01% |
910,400
-204,900
| -18% | -$5.21M |
|
1603
PUT
ArcelorMittal
MT
$55.7B
| $23.8M | 0.01% |
1,052,900
-16,100
| -2% | -$472K |
|
1604
CALL
Consolidated Edison
ED
$40.2B
| $23.8M | 0.01% |
250,000
+46,800
| +23% | +$4.46M |
|
1605
CALL
Advance Auto Parts
AAP
$3.41B
| $23.7M | 0.01% |
137,000
+78,600
| +135% | +$15.6M |
|
1606
CALL
Bio-Rad Laboratories Class A
BIO
$9.53B
| $23.7M | 0.01% |
47,800
+4,500
| +10% | +$2.34M |
|
1607
SS&C Technologies
SSNC
$19.1B
| $23.6M | 0.01% |
407,220
+376,970
| +1,246% | +$24.2M |
|
1608
Liberty Energy
LBRT
$3.59B
| $23.6M | 0.01% |
1,851,344
+970,843
| +110% | +$15.2M |
|
1609
State Street Utilities Select Sector SPDR ETF
XLU
$23B
| $23.6M | 0.01% |
673,018
+459,600
| +215% | +$16.6M |
|
1610
Air Products & Chemicals
APD
$68.8B
| $23.6M | 0.01% |
97,971
-123,055
| -56% | -$29.9M |
|
1611
PUT
Dell
DELL
$317B
| $23.5M | 0.01% |
508,900
-223,000
| -30% | -$10.5M |
|
|
KVSA
1612
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $23.5M | 0.01% |
2,412,014
+36,659
| +2% | +$358K |
|
1613
PUT
HF Sinclair
DINO
$16.7B
| $23.5M | 0.01% |
520,200
+107,800
| +26% | +$4.83M |
|
|
SAVE
1614
DELISTED
Spirit Airlines, Inc.
SAVE
| $23.5M | 0.01% |
985,360
-316,252
| -24% | -$7.01M |
|
1615
CALL
AB InBev
BUD
$157B
| $23.4M | 0.01% |
433,800
-339,800
| -44% | -$19.1M |
|
1616
Alliant Energy
LNT
$18.3B
| $23.4M | 0.01% |
398,872
+225,516
| +130% | +$13.6M |
|
1617
PUT
RingCentral
RNG
$5.39B
| $23.4M | 0.01% |
447,300
-32,600
| -7% | -$2.47M |
|
|
MSDA
1618
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
| $23.4M | 0.01% |
2,384,427
+3,039
| +0.1% | +$29.8K |
|
|
HERA
1619
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $23.3M | 0.01% |
2,381,524
-1,339,441
| -36% | -$13.1M |
|
1620
PUT
Affirm
AFRM
$26.2B
| $23.3M | 0.01% |
1,291,500
-784,800
| -38% | -$21.3M |
|
1621
PUT
Cadence Design Systems
CDNS
$89.5B
| $23.3M | 0.01% |
155,300
+62,100
| +67% | +$9.38M |
|
1622
Amcor
AMCR
$21.3B
| $23.3M | 0.01% |
374,504
+285,126
| +319% | +$17.6M |
|
1623
Franklin Resources
BEN
$17.2B
| $23.3M | 0.01% |
998,066
+492,448
| +97% | +$12.6M |
|
1624
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.6B
| $23.3M | 0.01% |
632,200
-58,600
| -8% | -$2.45M |
|
1625
CALL
Axsome Therapeutics
AXSM
$11.2B
| $23.3M | 0.01% |
607,200
-173,300
| -22% | -$5.48M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.